NVCR Novocure

NASDAQ
$16.22

Novocure (NVCR) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with NVCR's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
14
25 transactions
Purchases
$0
0 shares
Sales
$3.3M
228,161 shares
Net activity
-$3.3M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $3.3M 25 transactions · 228,161 shares

Largest single sale: $646.4K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: September 5, 2025 — 1.0 years ago, by Cordova Ashley .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Leonard Frank X Chief Executive Officer Sell 34,273 $17.93 $614.6K 459,520 −6.9% of holding
HILLEMAN JERYL L Director Sell 2,945 $15.77 $46.4K 13,861 −17.5% of holding
LEUNG GABRIEL Director Sell 2,945 $15.77 $46.4K 89,499 −3.2% of holding
Hung David Director Sell 2,945 $15.77 $46.4K 20,465 −12.6% of holding
VERNON W ANTHONY Director Sell 2,945 $15.77 $46.4K 197,657 −1.5% of holding
Scannell Timothy J Director Sell 2,945 $15.77 $46.4K 14,288 −17.1% of holding
Ocean Allyson J Director Sell 2,945 $15.77 $46.4K 11,324 −20.6% of holding
Stafford Kristin Director Sell 2,945 $15.77 $46.4K 11,324 −20.6% of holding
Paravasthu Mukund Chief Operating Officer Sell 43,246 $13.77 $595.7K 72,832 −37.3% of holding
Brackmann Christoph Chief Financial Officer Sell 6,412 $13.31 $85.3K 182,842 −3.4% of holding
Weinberg Uri Chf Medical and Innovation Ofr Sell 6,412 $13.31 $85.3K 267,190 −2.3% of holding
Leonard Frank X Chief Executive Officer Sell 5,607 $13.31 $74.6K 493,793 −1.1% of holding
Paravasthu Mukund Chief Operating Officer Sell 5,377 $13.31 $71.5K 116,078 −4.4% of holding
Puri Michal Nath Chief Human Resources Officer Sell 1,100 $13.31 $14.6K 201,322 −0.5% of holding
Leupin Nicolas Former Chief Medical Officer Sell 1,100 $13.31 $14.6K 102,979 −1.1% of holding
DOYLE WILLIAM F 2 fills Executive Chairman Sell 71,887 $12.98 $932.9K 349,727 −17.1% of holding
Leonard Frank X Chief Executive Officer Sell 7,232 $13.49 $97.6K 349,400 −2% of holding
Weinberg Uri Chf Medical and Innovation Ofr Sell 3,272 $13.33 $43.6K 223,477 −1.4% of holding
Paravasthu Mukund Chief Operating Officer Sell 408 $13.49 $5.5K 76,343 −0.5% of holding
Leonard Frank X Chief Executive Officer Sell 9,734 $13.66 $133.0K 338,011 −2.8% of holding
Weinberg Uri Chf Medical and Innovation Ofr Sell 7,461 $13.84 $103.3K 213,757 −3.4% of holding
Paravasthu Mukund Chief Operating Officer Sell 1,555 $13.66 $21.2K 76,751 −2% of holding
Puri Michal Nath Chief Human Resources Officer Sell 1,441 $13.66 $19.7K 162,322 −0.9% of holding
Leupin Nicolas Former Chief Medical Officer Sell 1,029 $13.66 $14.1K 104,079 −1% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.